Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: wvalx who wrote (19621)	3/11/1999 9:01:00 PM
From: VLAD	Read Replies (2) \| Respond to of 23519

wvalx, A lot of doctors never see much of their mail. Often their secretaty/office manager weeds through the mail before it hits the doctor's desk. Drug/product mailings often end in the circular file before the doctor sees them. Often times even when the mail is not screened by the help this type of stuff gets pitched by the doctor due to a lack of time or a lack of interest. There is a big difference between marketing via mailing vs having a sales rep meet in person to detail/promote a product. I'm looking forward to Astra/Zeneca signing up as Vivus' domestic marketing partner in the near future. If and when such an event occurs, you can expect the share price to triple or quadruple in a matter of a few days.